A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Accolade, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 128,765 shares of ACCD stock, worth $497,032. This represents 0.0% of its overall portfolio holdings.

Number of Shares
128,765
Previous 113,082 13.87%
Holding current value
$497,032
Previous $1.19 Million 61.18%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$3.58 - $10.13 $56,145 - $158,868
15,683 Added 13.87%
128,765 $460,000
Q1 2024

May 09, 2024

BUY
$9.22 - $15.02 $884,493 - $1.44 Million
95,932 Added 559.37%
113,082 $1.19 Million
Q4 2023

Feb 09, 2024

SELL
$6.5 - $12.85 $205,601 - $406,458
-31,631 Reduced 64.84%
17,150 $205,000
Q3 2023

Nov 13, 2023

BUY
$10.45 - $15.02 $509,761 - $732,690
48,781 New
48,781 $516,000

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $278M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.